Lv2
128 积分 2024-06-30 加入
ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer
29天前
已完结
Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer
29天前
已完结
Daraxonrasib in Previously Treated Advanced RAS -Mutated Pancreatic Cancer
30天前
已完结
Improving surgical treatments for hepatocellular carcinoma
1个月前
已完结
Trastuzumab Deruxtecan in Residual HER2-Positive Early Breast Cancer
1个月前
已完结
Treatment of NSCLC after chemoimmunotherapy — are we making headway?
2个月前
已完结
Navigating the landscape of EGFR TKI resistance in EGFR-mutant NSCLC — mechanisms and evolving treatment approaches
2个月前
已完结
Advances in Lung Cancer Basic and Translational Research in 2025 – Overview and Perspectives Focusing on NSCLC
2个月前
已完结
The current and emerging immunotherapy paradigm in small-cell lung cancer
2个月前
已完结
A Roadmap to Precision Immunotherapy for Early-Stage Non–Small Cell Lung Cancer
2个月前
已完结
皖公网安备34019202002308
